ATEROVAX is an in vitro diagnostic (IVD) company located in Paris, France, focusing on the development of innovative patent-protected in vitro diagnostic products for improving management of cardiovascular diseases. The mission of ATEROVAX is to help reduce the number of cardiovascular events by providing physicians with powerful diagnostic tools that will enable them to take preventive measures before it is too late.